Bernstein raised the firm’s price target on Molina Healthcare (MOH) to $224 from $182 and keeps an Outperform rating on the shares. The firm sees a sector turnaround in the government managed care organization sector beginning in 2026, but expects to see bumps in the recovery. Bernstein believes all MCO sectors present attractive entry points, with Medicare Advantage likely to see the nearest term earnings improvements and Medicaid representing the most attractive valuations.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare price target lowered to $175 from $190 at Truist
- Molina Healthcare price target raised to $164 from $144 at Barclays
- Early notable gainers among liquid option names on December 31st
- Early notable gainers among liquid option names on December 30th
- Trump Trade: Trump strikes deals with nine drugmakers to cut prices
